This inventor holds 1 USPTO granted patent. Top assignee: S&k Therapeutics. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Wook-Young Baek: Innovator in Therapeutic Compounds
Introduction
Wook-Young Baek is a prominent inventor based in Hwaseong, South Korea. He has made significant contributions to the field of therapeutic agents, particularly in the area of autoimmune diseases. His innovative work has led to the development of novel compounds that show promise in treating various inflammatory conditions.
Latest Patents
Wook-Young Baek holds a patent for "Small-molecule compounds for controlling endosomal toll-like receptors and therapeutic agent for autoimmune diseases using same." This patent describes antagonistic small-molecule compounds that inhibit endosomal Toll-like receptors (TLRs), specifically targeting TLR3, TLR7, TLR8, and TLR9 signaling pathways. The compounds have demonstrated significant efficacy in a systemic lupus erythematosus animal model by preventing TNF-α secretion and inhibiting the production of inflammatory cytokines. This suggests their potential utility in preventing or treating TLR-associated autoimmune diseases, inflammatory diseases, and viral diseases.
Career Highlights
Wook-Young Baek is affiliated with S&K Therapeutics, where he continues to advance his research and development efforts. His work is characterized by a strong focus on innovative therapeutic solutions that address unmet medical needs.
Collaborations
Wook-Young Baek collaborates with notable colleagues, including Yangseon Choi and Kevin Jaesuk Choi. Their combined expertise enhances the research and development efforts at S&K Therapeutics.
Conclusion
Wook-Young Baek is a key figure in the development of small-molecule compounds aimed at treating autoimmune diseases. His innovative contributions and collaborations position him as a significant inventor in the field of therapeutic agents.